CRBU ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 11, 2023 in the Class Action Filed on Behalf of Caribou Biosciences, Inc. Shareholders
NEW YORK, March 21, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Caribou Biosciences, Inc. CRBU alleging that the Company violated federal securities laws.
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Caribou common stock pursuant and/or traceable to documents issued in connection with the Company's initial public offering conducted on or about July 23, 2021; and/or (b) Caribou securities between July 23, 2021, and December 9, 2022.
Lead Plaintiff Deadline: April 11, 2023
No obligation or cost to you.
Learn more about your recoverable losses in CRBU:
https://www.kleinstocklaw.com/pslra-1/caribou-biosciences-inc-loss-submission-form?id=37442&from=4
Caribou Biosciences, Inc. NEWS - CRBU NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that Caribou Biosciences, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the treatment effect of the Company's product candidate, CB-010, was not as durable as defendants had led investors to believe; (ii) accordingly, CB-010's clinical and commercial prospects were overstated; and (iii) as a result, documents issued in connection with Caribou's initial public offer and defendants' public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.
WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Caribou you have until April 11, 2023 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you purchased Caribou securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.
HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the CRBU lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link: https://www.kleinstocklaw.com/pslra-1/caribou-biosciences-inc-loss-submission-form?id=37442&from=4.
ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
535 Fifth Avenue
4th Floor
New York City, NY 10017
jk@kleinstocklaw.com
Telephone: (212) 616-4899
www.kleinstocklaw.com
SOURCE The Klein Law Firm
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
